Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups : A systematic review and meta-analysis
© 2023 The Author(s)..
Objectives: Understanding COVID-19 vaccine hesitancy among migrant and refugee groups is critical for achieving vaccine equity. Therefore, we aimed to estimate the prevalence of COVID-19 vaccine acceptance among migrant and refugee populations.
Methods: A systematic review (PROSPERO: CRD42022333337) was conducted (December 2019-July 2022) using PubMed, Scopus, Web of Science, ProQuest and Google Scholar.
Results: Nineteen studies from 12 countries were included. The pooled estimated prevalence of COVID-19 vaccine willingness among migrant and refugee groups was 70% (19 studies, 95% CI: 62.3-77.4%, I2: 99.19%, τ2: 0.03). Female and male participants did not differ significantly with each other (p = 0.64). Although no individual variable contributed statistically significantly in multivariable meta-regression analysis, the multivariable model that considered methodological quality, mean age of participants, participant group and country of origin explained 67% of variance.
Discussion: Proportions of migrant/refugee groups receiving COVID-19 vaccinations approximated those observed among general populations. Additional studies are needed to examine factors relating to vaccine willingness to identify the most significant factors that may be targeted in interventions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Vaccine: X - 14(2023) vom: 24. Aug., Seite 100308 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Alimoradi, Zainab [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acceptance |
---|
Anmerkungen: |
Date Revised 12.03.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.jvacx.2023.100308 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357254643 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM357254643 | ||
003 | DE-627 | ||
005 | 20240312233043.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jvacx.2023.100308 |2 doi | |
028 | 5 | 2 | |a pubmed24n1324.xml |
035 | |a (DE-627)NLM357254643 | ||
035 | |a (NLM)37223070 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alimoradi, Zainab |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups |b A systematic review and meta-analysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Author(s). | ||
520 | |a Objectives: Understanding COVID-19 vaccine hesitancy among migrant and refugee groups is critical for achieving vaccine equity. Therefore, we aimed to estimate the prevalence of COVID-19 vaccine acceptance among migrant and refugee populations | ||
520 | |a Methods: A systematic review (PROSPERO: CRD42022333337) was conducted (December 2019-July 2022) using PubMed, Scopus, Web of Science, ProQuest and Google Scholar | ||
520 | |a Results: Nineteen studies from 12 countries were included. The pooled estimated prevalence of COVID-19 vaccine willingness among migrant and refugee groups was 70% (19 studies, 95% CI: 62.3-77.4%, I2: 99.19%, τ2: 0.03). Female and male participants did not differ significantly with each other (p = 0.64). Although no individual variable contributed statistically significantly in multivariable meta-regression analysis, the multivariable model that considered methodological quality, mean age of participants, participant group and country of origin explained 67% of variance | ||
520 | |a Discussion: Proportions of migrant/refugee groups receiving COVID-19 vaccinations approximated those observed among general populations. Additional studies are needed to examine factors relating to vaccine willingness to identify the most significant factors that may be targeted in interventions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Acceptance | |
650 | 4 | |a COVID-19 vaccination | |
650 | 4 | |a Immigration | |
650 | 4 | |a Minority | |
700 | 1 | |a Sallam, Malik |e verfasserin |4 aut | |
700 | 1 | |a Jafari, Elahe |e verfasserin |4 aut | |
700 | 1 | |a Potenza, Marc N |e verfasserin |4 aut | |
700 | 1 | |a Pakpour, Amir H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccine: X |d 2019 |g 14(2023) vom: 24. Aug., Seite 100308 |w (DE-627)NLM299955931 |x 2590-1362 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2023 |g day:24 |g month:08 |g pages:100308 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jvacx.2023.100308 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2023 |b 24 |c 08 |h 100308 |